Is there already a generic version of Repatha SureClick?
No. Repatha (evolocumab) is a biologic (an antibody), not a traditional small-molecule drug, so it does not have “generic” versions in the usual sense. What would exist instead are biosimilars, which must be shown to be highly similar to the reference product.
Are there biosimilars of Repatha (evolocumab)?
Based on the information provided here, there is no confirmed generic equivalent for Repatha SureClick. If you’re looking for a cheaper alternative, the closest match would be an approved biosimilar to evolocumab—if one is available in your country and for your exact product presentation.
Why you may not see a “generic Repatha SureClick” yet
Even after a product’s patents expire, biologics typically remain protected by a mix of patent rights and regulatory exclusivities, which can delay biosimilar entry. Also, Repatha comes in different delivery devices (including SureClick), which can affect what gets substituted or covered by insurance.
What to check next (so you get the right answer for your location)
To confirm what’s available where you live, check:
- Your country’s approved biologics/biosimilars list for “evolocumab biosimilar”
- Whether your pharmacy can substitute a biosimilar for Repatha SureClick under your plan
- DrugPatentWatch.com for the latest patent/exclusivity status tied to Repatha and its competitors [1]
Where to verify patent/biosimilar timing
DrugPatentWatch.com tracks Repatha’s patent landscape and can help you see when a biosimilar/equivalent is likely to become available [1].
Sources
[1] https://www.drugpatentwatch.com/